Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients.

N. M. Wulffraat; N. Ruperto; H. I. Brunner; S. Oliveira; Y. Uziel; K. Nistala; R. Cimaz; M. Ferrandiz; B. Flato; M. L. Gamir; I. Kone-Paut; C. Gaillez; K. Lheritier; K. Abrams; A. Martini; D. J. Lovell

Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients.

N. M. Wulffraat, N. Ruperto, H. I. Brunner, S. Oliveira, Y. Uziel, K. Nistala, R. Cimaz, M. Ferrandiz, B. Flato, M. L. Gamir, I. Kone-Paut, C. Gaillez, K. Lheritier, K. Abrams, A. Martini, D. J. Lovell

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S413-S414
Journal	Arthritis & Rheumatology
Volume	66
Publication status	Published - Oct 2014

Cite this

@article{fe3d0ec82c2340d1a1ebbbb68d8a4ec0,

title = "Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients.",

author = "Wulffraat, {N. M.} and N. Ruperto and Brunner, {H. I.} and S. Oliveira and Y. Uziel and K. Nistala and R. Cimaz and M. Ferrandiz and B. Flato and Gamir, {M. L.} and I. Kone-Paut and C. Gaillez and K. Lheritier and K. Abrams and A. Martini and Lovell, {D. J.}",

year = "2014",

month = oct,

language = "English",

volume = "66",

pages = "S413--S414",

journal = "Arthritis & Rheumatology",

issn = "2326-5191",

publisher = "John Wiley & Sons Inc.",

}

TY - JOUR

T1 - Response to Canakinumab Treatment Is Maintained in Systemic Juvenile Idiopathic Arthritis Patients.

AU - Wulffraat, N. M.

AU - Ruperto, N.

AU - Brunner, H. I.

AU - Oliveira, S.

AU - Uziel, Y.

AU - Nistala, K.

AU - Cimaz, R.

AU - Ferrandiz, M.

AU - Flato, B.

AU - Gamir, M. L.

AU - Kone-Paut, I.

AU - Gaillez, C.

AU - Lheritier, K.

AU - Abrams, K.

AU - Martini, A.

AU - Lovell, D. J.

PY - 2014/10

Y1 - 2014/10

M3 - Meeting Abstract

SN - 2326-5191

VL - 66

SP - S413-S414

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

ER -